Leading Brazilian Information Security Specialist Kryptus Expands Its Activities in the EMEA Region
12.5.2020 17:55:00 EEST | Business Wire | Press release
Seeking to consolidate its presence and develop new businesses in Europe, Middle East and Africa (EMEA), Brazilian Kryptus, specialized in cryptography and information security, announces the expansion of its international activities with the opening of a new unit of the company in Switzerland. The initiative is focused on offering technical support in the region, as well as develop the market, regional channel partners, and respond to local requirements. The move includes the announcement of Thierry Martin as the new director for EMEA and the head of the Swiss branch.
With a strong cybersecurity background, Martin is an engineer who has led several different technology companies in Europe and Brazil. The executive has also been a member of the Kryptus board in 2016 and 2017.
Currently providing solutions to financial institutions, private companies, and governments around the globe, Kryptus aims through this expansion to reach more customers with its competitive and unique product portfolio. The offerings include kNET, its high-performance HSM with unbreakable encryption, and Commguard, its flexible line of link encryptors.
"Kryptus can deliver world-class, trustworthy, and secure cryptography solutions for critical applications. Our presence in the region allows the optimization of services for customized or custom-developed products, providing a strong value proposition in the EMEA region," says Thierry Martin.
According to Roberto Gallo, founder & CEO of Kryptus, expanding to the EMEA region strengthens the company's position as a strategic provider of cyberdefense for governments and enterprises. "Kryptus can now extend its technology offering to Europe, Middle East, and Africa, based on relevant certifications and high performance," he points out.
With its Headquarter in Campinas, Kryptus was founded in 2003 and counts among its customers companies like BSH (a BOSCH Gmbh subsidiary), Claro Brasil (America Móvil Group), Certisign (exclusive Verisign partner in Brazil), Iron Mountain, iFood and Embraer. Granted the status of Strategic Defense Company (EED) by the Brazilian Defense Council, Kryptus has gained the trust - as a supplier from a neutral country - of several government agencies to protect their sovereignty. Among such customers with the highest security requirements, Kryptus delivered government-grade solutions to the Peruvian Navy, the Colombian Army and the Brazilian Army, Air Force, Navy, Intelligence Agency, Ministry of Foreign Affairs, and Superior Electoral Court, as well as to several other governments.
About Thierry Martin
Thierry Martin was born in Switzerland where he studied Electronics and Computer Science. He has professional experience in various areas of technology, among them Digital TV, Cyber Security, Electronics, and Telecommunications. Along his career he has lived and worked in Switzerland, Spain, the United Kingdom, and Brazil, as well as worked extensively with the United States and Asia. He has held executive positions in companies like Nagra, Kudelski Security, Selectron Systems AG, and Mouvent AG.
About Kryptus
Kryptus is a provider of solutions in Information Security. With 17 years of history and HQ in Campinas (SP), Kryptus SA is an independent Brazilian company that has been growing consistently for the past 10 years, focusing on long term actions, scientific and technological plans, and understanding the mission of its clients in the business lines it develops. Kryptus is a partner of the Kudelski Group. Kryptus is a Brazilian Strategic Defense Company (EED), a status granted by the Brazilian Defense Council.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005624/en/
Contact information
Thierry Martin
+41 79 932 19 23
thierry.martin@kryptus.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom